Australian Parkinson's Mission

Improving quality of life for people living with Parkinson’s — and discovering how to slow, stop and cure the disease.

The Australian Parkinson's Mission, an innovative 5 year research program, combines clinical trials and biomarker technologies with breakthrough genomics for people living with Parkinson's.

We hope to identify and validate a precision medicine framework for treating and preventing Parkinson's disease. 

Coronavirus information for patients 
The APM clinical trials were due to commence recruitment shortly, however, unfortunately due to COIVID-19 these will now be delayed. We will continue to keep you updated on recruitment timeframes for APM clinical trials via this website. Please read APMs response to COVID-19 protocols (30 March 2020)


The Australian Parkinson's Mission (APM) is an innovative research program combining clinical trials with genomics research for people with Parkinson’s.

The APM is an Australian-led international collaboration between the Garvan Institute of Medical Research, Shake It Up Australia Foundation, the University of Sydney, the Cure Parkinson’s Trust (UK), Michael J Fox Foundation (USA) and Parkinson’s Australia.



Phone: 1300 770 577

Contact us ⟶